Nan Fung Group Holdings Ltd - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 54 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Nan Fung Group Holdings Ltd ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$775,496
+4.4%
49,0820.0%0.63%
+32.2%
Q2 2023$743,101
-30.4%
49,082
-33.3%
0.48%
-34.6%
Q1 2023$1,066,939
+7.2%
73,5820.0%0.73%
+6.0%
Q4 2022$994,829
-55.4%
73,582
-48.0%
0.68%
-51.9%
Q3 2022$2,232,000
+5.6%
141,593
-18.4%
1.42%
-1.9%
Q2 2022$2,114,000
+29.7%
173,5820.0%1.45%
+87.8%
Q1 2022$1,630,000173,5820.77%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$64,173,86826.74%
5AM Venture Management, LLC 4,408,379$63,921,49616.35%
72 Investment Holdings, LLC 509,023$7,380,8333.50%
StepStone Group LP 761,277$11,038,5172.05%
TCG Crossover Management, LLC 584,955$8,481,8481.65%
Redmile Group, LLC 1,831,608$26,558,3161.15%
Nan Fung Group Holdings Ltd 73,582$1,066,9390.73%
Baker Brothers Advisors 4,865,819$70,554,3760.38%
CHI Advisors LLC 56,374$817,4230.22%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,522,5000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders